Did you know there’s even more we can do to promote your episode? Find out more…
Episode 185
The diamond in the rough
Kent Payne
/ Aliri Bioanalysis
Kent Payne, CEO at Aliri discusses the value of scientists engaging with clients to build relationships and showcase technical expertise.
Episode 184
One-hour special – The President of the PBOA
Gil Roth
/ Pharma & Biopharma Outsourcing Association (PBOA)
Gil Roth, PBOA President, joins the podcast to discuss the latest pharma and biopharma industry news, plus green shoots to watch out for.
Episode 183
The puzzle-solving CEO
Steven Chevillotte
/ SaniSure
Steven Chevillotte joins Molecule to Market to discuss the key elements that have played a role in the continued success of SaniSure.
Episode 182
Summer sentiment: A life science industry check-in & where you’ll find me
Raman Sehgal
/ Molecule to Market
Join Raman Sehgal for a quick update on the life sciences sector’s current state amid market challenges and where to find him on the road.
Episode 181
Pivoting to partnership success in clinical trial
Yussuf Goolam
/ RxSource
Yussuf Goolam, Co-Founder, President and CEO of RxSource, recently spoke about his incredible journey into the clinical trials space.
Episode 180
A Sterling, CDMO leader
Kevin Cook
/ Sterling Pharma Solutions
Kevin Cook, CEO at Sterling Pharma Solutions spoke on his key tips to mastering M&A and growing exponentially in the North American market.
Episode 179
AI as a force for good in drug development
Vijay Vaswani
/ Omniscope
Vijay Vaswani joins Molecule to Market to discuss how you should be thinking about AI for drug discovery and drug development.
Episode 178
Harnessing tech to improve the economics of making medicine
David Staunton
/ Cognizant
Cognizant’s David Staunton discusses the transformative impact of GenAI on the life sciences industry, accelerating drug development and revolutionizing healthcare.
Episode 177
Tasty Topics: Addressing the potential impact of the BIOSECURE Act
Tom Wilson, Hanna Lesch & Stephen Grant
/ Pfizer CentreOne, Exothera
In this new episode we speak to sector experts who give their opinions on the potential impacts of the BIOSECURE Act in the USA.
Episode 176
Becoming…a world class scientific leader
Mihaela Simianu
/ Singota Solutions
Listen to Mihaela Simianu from Singota Solutions’ insights on driving innovation in biopharma for personalized medicine and public health.
